{
  "id": 18900317,
  "title": "Chemed executive vice president Lee sells $494,196 in stock",
  "url": "https://urgent.news/2026/11/08/chemed-executive-vice-president-lee-sells-494-196-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-08T08:30:56.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/chemed-executive-vice-president-lee-sells-494196-in-stock-93CH-5010162"
  },
  "original_language": "en",
  "account": "Spencer S. Lee, an executive vice president at Chemed Corp., recently sold 920 shares of the company's stock on November 2, 2026, for a total of $494,196. The sale price per share ranged from $536.26 to $537.70, occurring when the stock was trading near its 52-week high of $562.24, currently valued at $528.05. After this transaction, Lee held 13,931 shares of Chemed capital stock directly.\n\nChemed has a solid reputation as a shareholder-friendly company, having increased its dividend for 17 consecutive years according to InvestingPro analysis. The current dividend yield stands at 0.53%, with the stock currently trading below its Fair Value and listed among InvestingPro's undervalued stocks. Investors seeking more detailed insights can access the Pro Research Report for CHE and 1,400+ other US equities.\n\nRecently, Chemed Corp. reported its third-quarter 2026 earnings, surpassing Wall Street expectations. Adjusted diluted earnings per share rose to $6.75, exceeding the forecast of $6.44. Revenue for the quarter increased to $690.9 million, surpassing the anticipated $685.04 million. This growth was primarily attributed to the strong performance of Chemed's VITAS hospice unit and steady revenue gains at Roto-Rooter.\n\nThese financial results demonstrate Chemed's ability to outperform financial projections and maintain robust revenue streams. Analyst firms have noted the company's strong earnings performance, with no recent upgrades or downgrades reported. Chemed's recent success brings it closer to its 52-week high, making it an important development for investors monitoring the company's financial health.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}